152 related articles for article (PubMed ID: 29620286)
1. Diallyl disulfide inhibits TGF‑β1‑induced upregulation of Rac1 and β‑catenin in epithelial‑mesenchymal transition and tumor growth of gastric cancer.
Su B; Su J; Zeng Y; Ding E; Liu F; Tan T; Xia H; Wu YH; Zeng X; Ling H; Jiang H; Ai XH; Su Q
Oncol Rep; 2018 Jun; 39(6):2797-2806. PubMed ID: 29620286
[TBL] [Abstract][Full Text] [Related]
2. Diallyl disulfide suppresses epithelial-mesenchymal transition, invasion and proliferation by downregulation of LIMK1 in gastric cancer.
Su B; Su J; Zeng Y; Liu F; Xia H; Ma YH; Zhou ZG; Zhang S; Yang BM; Wu YH; Zeng X; Ai XH; Ling H; Jiang H; Su Q
Oncotarget; 2016 Mar; 7(9):10498-512. PubMed ID: 26871290
[TBL] [Abstract][Full Text] [Related]
3. Diallyl disulfide inhibits growth and metastatic potential of human triple-negative breast cancer cells through inactivation of the β-catenin signaling pathway.
Huang J; Yang B; Xiang T; Peng W; Qiu Z; Wan J; Zhang L; Li H; Li H; Ren G
Mol Nutr Food Res; 2015 Jun; 59(6):1063-75. PubMed ID: 25755089
[TBL] [Abstract][Full Text] [Related]
4. P21 activated kinase-1 mediates transforming growth factor β1-induced prostate cancer cell epithelial to mesenchymal transition.
Al-Azayzih A; Gao F; Somanath PR
Biochim Biophys Acta; 2015 May; 1853(5):1229-39. PubMed ID: 25746720
[TBL] [Abstract][Full Text] [Related]
5. Silibinin attenuates TGF‑β1‑induced migration and invasion via EMT suppression and is associated with COX‑2 downregulation in bladder transitional cell carcinoma.
Li F; Sun Y; Jia J; Yang C; Tang X; Jin B; Wang K; Guo P; Ma Z; Chen Y; Wang X; Chang L; He D; Zeng J
Oncol Rep; 2018 Dec; 40(6):3543-3550. PubMed ID: 30272315
[TBL] [Abstract][Full Text] [Related]
6. [Antitumor effect of diallyl disulfide on human gastric cancer MGC803 cells xenograft in nude mice].
Xiang SL; Xiao XL; Ling H; Liao QJ; Zhou XT; Dong L; Su Q
Ai Zheng; 2005 Aug; 24(8):940-4. PubMed ID: 16086870
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of BMP‑7 reverses TGF‑β1‑induced epithelial‑mesenchymal transition by attenuating the Wnt3/β‑catenin and TGF-β1/Smad2/3 signaling pathways in HK‑2 cells.
Song Y; Lv S; Wang F; Liu X; Cheng J; Liu S; Wang X; Chen W; Guan G; Liu G; Peng C
Mol Med Rep; 2020 Feb; 21(2):833-841. PubMed ID: 31974602
[TBL] [Abstract][Full Text] [Related]
8. Effect of the alteration of Tribbles homologue 3 expression on epithelial‑mesenchymal transition of transforming growth factor β1‑induced mouse alveolar epithelial cells through the Wnt/β‑catenin signaling pathway.
Yu W; Mi L; Wang F
Mol Med Rep; 2020 Feb; 21(2):615-622. PubMed ID: 31974597
[TBL] [Abstract][Full Text] [Related]
9. DADS downregulates the Rac1-ROCK1/PAK1-LIMK1-ADF/cofilin signaling pathway, inhibiting cell migration and invasion.
Zhou Y; Su J; Shi L; Liao Q; Su Q
Oncol Rep; 2013 Feb; 29(2):605-12. PubMed ID: 23233092
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of miR‑483‑5p inhibits TGF‑β1‑induced EMT by targeting RhoGDI1 in pulmonary fibrosis.
Huang G; Zhang J; Qing G; Liu D; Wang X; Chen Y; Wu Y; Li Y; Guo S
Mol Med Rep; 2021 Jul; 24(1):. PubMed ID: 34080651
[TBL] [Abstract][Full Text] [Related]
11. Diallyl disulfide induces downregulation and inactivation of cofilin 1 differentiation via the Rac1/ROCK1/LIMK1 pathway in leukemia cells.
Ling H; Ji X; Lei Y; Jia Y; Liu F; Xia H; Tan H; Zeng X; Yi L; He J; Su Q
Int J Oncol; 2020 Mar; 56(3):772-782. PubMed ID: 32124958
[TBL] [Abstract][Full Text] [Related]
12. Metformin inhibits TGF‑β1‑induced epithelial‑mesenchymal transition and liver metastasis of pancreatic cancer cells.
Yoshida J; Ishikawa T; Endo Y; Matsumura S; Ota T; Mizushima K; Hirai Y; Oka K; Okayama T; Sakamoto N; Inoue K; Kamada K; Uchiyama K; Takagi T; Naito Y; Itoh Y
Oncol Rep; 2020 Jul; 44(1):371-381. PubMed ID: 32627027
[TBL] [Abstract][Full Text] [Related]
13. Metformin suppresses the invasive ability of pancreatic cancer cells by blocking autocrine TGF‑β1 signaling.
Duan W; Qian W; Zhou C; Cao J; Qin T; Xiao Y; Cheng L; Li J; Chen K; Li X; Ma J; Ma Q
Oncol Rep; 2018 Sep; 40(3):1495-1502. PubMed ID: 29956804
[TBL] [Abstract][Full Text] [Related]
14. Identification of potential targets for differentiation in human leukemia cells induced by diallyl disulfide.
Ling H; He J; Tan H; Yi L; Liu F; Ji X; Wu Y; Hu H; Zeng X; Ai X; Jiang H; Su Q
Int J Oncol; 2017 Feb; 50(2):697-707. PubMed ID: 28101575
[TBL] [Abstract][Full Text] [Related]
15. Identification of potential targets for diallyl disulfide in human gastric cancer MGC-803 cells using proteomics approaches.
Su B; Su J; He H; Wu Y; Xia H; Zeng X; Dai W; Ai X; Ling H; Jiang H; Su Q
Oncol Rep; 2015 May; 33(5):2484-94. PubMed ID: 25812569
[TBL] [Abstract][Full Text] [Related]
16. Expression of TRB3 promotes epithelial‑mesenchymal transition of MLE‑12 murine alveolar type II epithelial cells through the TGF‑β1/Smad3 signaling pathway.
Cheng W; Mi L; Tang J; Yu W
Mol Med Rep; 2019 Apr; 19(4):2869-2875. PubMed ID: 30720074
[TBL] [Abstract][Full Text] [Related]
17. Diallyl disulfide downregulating RhoGDI2 induces differentiation and inhibit invasion via the Rac1/Pak1/LIMK1 pathway in human leukemia HL-60 cells.
Hui T; Yiling J; Guangqun C; Ran L; Hui L; Lan Y; Jie H; Su Q
Environ Toxicol; 2023 May; 38(5):1063-1077. PubMed ID: 36793247
[TBL] [Abstract][Full Text] [Related]
18. TGF‑β1‑induced epithelial‑mesenchymal transition increases fatty acid oxidation and OXPHOS activity via the p‑AMPK pathway in breast cancer cells.
Liu QQ; Huo HY; Ao S; Liu T; Yang L; Fei ZY; Zhang ZQ; Ding L; Cui QH; Lin J; Yu M; Xiong W
Oncol Rep; 2020 Sep; 44(3):1206-1215. PubMed ID: 32705260
[TBL] [Abstract][Full Text] [Related]
19. Transforming growth factor β1 promotes migration and invasion in HepG2 cells: Epithelial‑to‑mesenchymal transition via JAK/STAT3 signaling.
Lin XL; Liu M; Liu Y; Hu H; Pan Y; Zou W; Fan X; Hu X
Int J Mol Med; 2018 Jan; 41(1):129-136. PubMed ID: 29115395
[TBL] [Abstract][Full Text] [Related]
20. Role of Rac1 Pathway in Epithelial-to-Mesenchymal Transition and Cancer Stem-like Cell Phenotypes in Gastric Adenocarcinoma.
Yoon C; Cho SJ; Chang KK; Park DJ; Ryeom SW; Yoon SS
Mol Cancer Res; 2017 Aug; 15(8):1106-1116. PubMed ID: 28461325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
